Indomethacin and phenylbutazone and its analogs are potent and useful in the management of patient with rheumatic disease but both have definite toxicity. Since the toxicity of phenylbutazone is more serious and can be detected only by laboratory testing, indomethacin is the drug of choice at the present time.